# Eosinophil-guided Reduction of Inhaled Corticosteroids

> **NCT04481555** · PHASE4 · COMPLETED · sponsor: **Chronic Obstructive Pulmonary Disease Trial Network, Denmark** · enrollment: 444 (actual)

## Conditions studied

- COPD
- Inhaled Corticosteroid
- Azithromycin
- COPD Exacerbation
- Pneumonia

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** ICS

## Key facts

- **NCT ID:** NCT04481555
- **Lead sponsor:** Chronic Obstructive Pulmonary Disease Trial Network, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-28
- **Primary completion:** 2024-11-27
- **Final completion:** 2025-11-19
- **Target enrollment:** 444 (ACTUAL)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04481555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04481555, "Eosinophil-guided Reduction of Inhaled Corticosteroids". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04481555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*